Skip to main content

Table 2 Patient characteristics associated with anti-TNF and DMARD use: logistic regression model

From: Hospitalization for musculoskeletal disorders in rheumatoid arthritis patients: a population-based study

Variables

2002–2006

2007–2011

 

OR (95 % CI)

OR (95 % CI)

 

Anti-TNF vs Non-users

DMARDs vs Non-users

Anti-TNF vs Non-users

DMARDs vs Non-users

Demographics

Residence (rural vs urbain)

1.21 (0.88, 1.66)

1.05 (0.81, 1.38)

1.43 (1.05, 1.96)

1.15 (0.87, 1.51)

Higher income

1.14 (0.90, 1.46)

1.02 (0.83, 1.26)

0.76 (0.59, 0.98)

0.70 (0.56, 0.87)

Socioeconomic status

Social quintile 0

1.02 (0.62, 1.68)

0.75 (0.48, 1.17)

1.33 (0.73, 2.41)

1.00 (0.59, 1.71)

Social quintile 2–3 versus 1

0.69 (0.48, 0.98)

0.69 (0.51, 0.93)

0.71 (0.49, 1.01)

0.72 (0.53, 0.98)

Social quintile 4–5 versus 1

0.61 (0.43, 0.88)

0.66 (0.49, 0.90)

0.82 (0.57, 1.18)

0.74 (0.54, 1.01)

Use of health services in prior year

Visit to rheumatologist

2.73 (1.97, 3.79)

1.74 (1.36, 2.22)

4.41 (3.27, 5.95)

2.86 (2.29, 3.60)

Comorbidity in prior year

Hematologic disorders

1.32 (0.90, 1.94)

0.92 (0.66, 1.28)

0.88 (0.60, 1.30)

0.96 (0.69, 1.32)

Heart failure

1.97 (0.84, 4.61)

1.95 (0.89, 4.29)

0.82 (0.41, 1.63)

0.52 (0.28, 0.94)

Cerebrovascular disease

1.43 (0.74, 2.75)

0.75 (0.39, 1.42)

0.38 (0.16, 0.86)

0.63 (0.35, 1.14)

Ischemic heart disease

1.06 (0.72, 1.55)

0.90 (0.64, 1.26)

0.97 (0.63, 1.50)

1.33 (0.93, 1.91)

Cancer

0.86 (0.55, 1.35)

1.17 (0.81, 1.69)

0.82 (0.56, 1.20)

0.88 (0.64, 1.22)

Medication use in prior year

NSAIDs

1.59 (1.21, 2.09)

1.26 (1.02, 1.58)

1.87 (1.46, 2.40)

1.66 (1.35, 2.05)

Serotonin reuptake inhibitors

0.93 (0.62, 1.39)

0.90 (0.65, 1.26)

1.08 (0.72, 1.63)

1.12 (0.79, 1.60)

Gastroprotective agents

1.04 (0.81, 1.33)

1.18 (0.95, 1.45)

1.09 (0.84, 1.42)

0.85 (0.68, 1.06)

Antidiabetics

1.39 (0.93, 2.08)

1.28 (0.89, 1.83)

0.76 (0.52, 1.09)

0.71 (0.53, 0.97)

Corticosteroid

1.87 (1.44, 2.43)

1.22 (0.99, 1.50)

1.92 (1.49, 2.47)

0.96 (0.78, 1.18)

Anticoagulants

0.90 (0.50, 1.62)

0.84 (0.52, 1.37)

0.98 (0.56, 1.71)

1.39 (0.89, 2.19)

Antihypertensives

1.21 (0.94, 1.57)

1.20 (0.97, 1.48)

0.93 (0.72, 1.21)

0.85 (0.68, 1.06)